Ebola vaccine trial interrupted for checks after joint pains - Geneva hospital

GENEVA, Dec 11 (Reuters) - A clinical trial of the Ebola vaccine by Merck and NewLink has been interrupted in all 59 volunteers in Geneva a week early "as a measure of precaution" after four patients complained of joint pains in hands and feet, the University of Geneva Hospital said on Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.